Related references
Note: Only part of the references are listed.Carvedilol induces biased β1 adrenergic receptor-nitric oxide synthase 3-cyclic guanylyl monophosphate signalling to promote cardiac contractility
Qingtong Wang et al.
CARDIOVASCULAR RESEARCH (2021)
Carvedilol induces biased β1 adrenergic receptor-nitric oxide synthase 3-cyclic guanylyl monophosphate signalling to promote cardiac contractility
Qingtong Wang et al.
CARDIOVASCULAR RESEARCH (2021)
Molecular mechanism of biased signaling in a prototypical G protein-coupled receptor
Carl-Mikael Suomivuori et al.
SCIENCE (2020)
Biased Signaling of the G-Protein-Coupled Receptor β2AR Is Governed by Conformational Exchange Kinetics
Rajan Lamichhane et al.
STRUCTURE (2020)
Molecular basis of β-arrestin coupling to formoterol-bound β1-adrenoceptor
Yang Lee et al.
NATURE (2020)
Strategies for the discovery of biased GPCR ligands
Marcel Bermudez et al.
DRUG DISCOVERY TODAY (2019)
Biased Receptor Signaling in Drug Discovery
Terry Kenakin
PHARMACOLOGICAL REVIEWS (2019)
Agonist-induced desensitisation of β3-adrenoceptors: Where, when, and how?
Katerina Okeke et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Hybridization of β-Adrenergic Agonists and Antagonists Confers G Protein Bias
Markus Stanek et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Does Divergent Binding Pocket Closure Drive Ligand Bias for Class A GPCRs?
Marcel Bermudez et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Everything You Always Wanted to Know about 3-AR * (* But Were Afraid to Ask)
Giorgia Schena et al.
CELLS (2019)
The EMBL-EBI search and sequence analysis tools APIs in 2019
Fabio Madeira et al.
NUCLEIC ACIDS RESEARCH (2019)
Detailed insight on β-adrenoceptors as therapeutic targets
Bharath Kumar Velmurugan et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Is the Quest for Signaling Bias Worth the Effort?
Terry Kenakin
MOLECULAR PHARMACOLOGY (2018)
Biased Agonism in Drug Discovery-Is It Too Soon to Choose a Path?
Martin C. Michel et al.
MOLECULAR PHARMACOLOGY (2018)
Lack of beta-arrestin signaling in the absence of active G proteins
Manuel Grundmann et al.
NATURE COMMUNICATIONS (2018)
A complex story of receptor signalling
Michael J. Capper et al.
NATURE (2018)
Structural determinants of 5-HT2B receptor activation and biased agonism
John D. McCorvy et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Manifold roles of beta-arrestins in GPCR signaling elucidated with siRNA and CRISPR/Cas9
Louis M. Luttrell et al.
SCIENCE SIGNALING (2018)
G protein-coupled receptor kinases (GRKs) orchestrate biased agonism at the beta(2)-adrenergic receptor
Minjung Choi et al.
SCIENCE SIGNALING (2018)
Pepducin-mediated cardioprotection via β-arrestin-biased β2-adrenergic receptor-specific signaling
Laurel A. Grisanti et al.
THERANOSTICS (2018)
Structural insights into binding specificity, efficacy and bias of a β2AR partial agonist
Matthieu Masureel et al.
NATURE CHEMICAL BIOLOGY (2018)
Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist
Pooneh Memar Ardestani et al.
NEUROPHARMACOLOGY (2017)
Discovery of novel brain permeable and G protein-biased beta-1 adrenergic receptor partial agonists for the treatment of neurocognitive disorders
Bitna Yi et al.
PLOS ONE (2017)
Gαi is required for carvedilol-induced β1 adrenergic receptor β-arrestin biased signaling
Jialu Wang et al.
NATURE COMMUNICATIONS (2017)
G Protein-coupled Receptor Biased Agonism
Sima Y. Hodavance et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2016)
Nebivolol versus Carvedilol or Metoprolol in Patients Presenting with Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction
Mehmet Ozaydin et al.
MEDICAL PRINCIPLES AND PRACTICE (2016)
β-Arrestin drives MAP kinase signalling from clathrin-coated structures after GPCR dissociation
K. Eichel et al.
NATURE CELL BIOLOGY (2016)
β-arrestin–biased signaling through the β2-adrenergic receptor promotes cardiomyocyte contraction
Richard Carr et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
A Review of Nebivolol Pharmacology and Clinical Evidence
Justin Fongemie et al.
DRUGS (2015)
Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser
Yanyong Kang et al.
NATURE (2015)
β-Arrestin-biased signaling mediates memory reconsolidation
Xing Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Salmeterol Efficacy and Bias in the Activation and Kinase-Mediated Desensitization of β2-Adrenergic Receptors
Luis E. Gimenez et al.
MOLECULAR PHARMACOLOGY (2015)
Role for β-arrestin in mediating paradoxical β2AR and PAR2 signaling in asthma
Julia K. L. Walker et al.
CURRENT OPINION IN PHARMACOLOGY (2014)
Divergent Transducer-specific Molecular Efficacies Generate Biased Agonism at a G Protein-coupled Receptor ( GPCR)
Ryan T. Strachan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Development and Characterization of Pepducins as Gs-biased Allosteric Agonists
Richard Carr et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Quantification of Ligand Bias for Clinically Relevant β2-Adrenergic Receptor Ligands: Implications for Drug Taxonomy
Emma T. van der Westhuizen et al.
MOLECULAR PHARMACOLOGY (2014)
β2-Agonist Therapy in Lung Disease
Mario Cazzola et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
The β-blocker Nebivolol Is a GRK/β-arrestin Biased Agonist
Catherine E. Erickson et al.
PLOS ONE (2013)
Structural insights into biased G protein-coupled receptor signaling revealed by fluorescence spectroscopy
Rita Rahmeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Divergent agonist selectivity in activating β1- and β2-adrenoceptors for G-protein and arrestin coupling
Ida Casella et al.
BIOCHEMICAL JOURNAL (2011)
Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down Syndrome: Activation of pradrenergic receptor by xamoterol as a potential cognitive enhancer
Mehrdad Faizi et al.
NEUROBIOLOGY OF DISEASE (2011)
Distinct Phosphorylation Sites on the β2-Adrenergic Receptor Establish a Barcode That Encodes Differential Functions of β-Arrestin
Kelly N. Nobles et al.
SCIENCE SIGNALING (2011)
Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling
Jillian G. Baker et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Functional Selectivity in Adrenergic and Angiotensin Signaling Systems
Chetan B. Patel et al.
MOLECULAR PHARMACOLOGY (2010)
Teaching old receptors new tricks: biasing seven-transmembrane receptors
Sudarshan Rajagopal et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Tissue functions mediated by β3-adrenoceptors-findings and challenges
Martin C. Michel et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2010)
Nebivolol The Somewhat-Different β-Adrenergic Receptor Blocker
Thomas Muenzel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
β-arrestins specifically constrain β2-adrenergic receptor signaling and function in airway smooth muscle
Deepak A. Deshpande et al.
FASEB JOURNAL (2008)
β-Blockers alprenolol and carvedilol stimulate β-arrestin-mediated EGFR transactivation
Il-Man Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A unique mechanism of β-blocker action:: Carvedilol stimulates β-arrestin signaling
James W. Wisler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Salmeterol stimulation dissociates β2-adrenergic receptor phosphorylation and internalization
Robert H. Moore et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
Targeting G protein-coupled receptor signaling in asthma
Deepak A. Deshpande et al.
CELLULAR SIGNALLING (2006)
Distinct signaling profiles of β1 and β2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy
Segolene Galandrin et al.
MOLECULAR PHARMACOLOGY (2006)
β-arrestin-dependent, G protein-independent ERK1/2 activation by the β2 adrenergic receptor
SK Shenoy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Characterization of isoprenaline- and salmeterol-stimulated interactions between β2-adrenoceptors and β-arrestin 2 using β-galactosidase complementation in C2C12 cells
AA Carter et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Transduction of receptor signals by β-arrestins
RJ Leftowitz et al.
SCIENCE (2005)
Evidence for pleiotropic signaling at the mouse β3-adrenoceptor revealed by SR59230A [3-(2-ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate]
DS Hutchinson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
PKA-mediated phosphorylation of the β1-adrenergic receptor promotes Gs/Gi switching
NP Martin et al.
CELLULAR SIGNALLING (2004)
Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta(2)-adrenergic receptor using phosphoserine-specific antibodies
TM Tran et al.
MOLECULAR PHARMACOLOGY (2004)
Agonist and inverse agonist actions of β-blockers at the human β2-adrenoceptor provide evidence for agonist-directed signaling
JG Baker et al.
MOLECULAR PHARMACOLOGY (2003)
β-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors
M Azzi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Protein kinase A-mediated phosphorylation of the β2-Adrenergic receptor regulates its coupling to Gs and Gi -: Demonstration in a reconstituted system
AM Zamah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Long-acting β2 agonists in the management of stable chronic obstructive pulmonary disease
M Cazzola et al.
DRUGS (2000)
Share Paper
